This is our final bulletin from CROI 2011. We hope you have
found our news coverage useful. You can find all our coverage at www.aidsmap.com/croi2011, including
reports and bulletins.We are always looking
for ways of improving and developing our resources – so if you have any comments
that you would like
increasing evidence of the transmission of HIV strains with resistance to
anti-HIV drugs in low- and middle-income countries.
Research in eleven sub-Saharan African countries showed that
the chances of detecting transmitted
resistance increased by over a third each year that a country had been scaling
up HIV treatment.
A separate study involving people recently diagnosed
new type of anti-HIV drug that targets the first step in HIV’s entry into cells
has done well in a Phase IIa study.
Currently known as BMS-663068, the drug was shown to be safe
and to work against the virus.
cell entry is a three-step process. The virus must first attach to the